¸¸¼ºº¯ºñ Ä¡·áÀÇ ÃÖ±Ù µ¿Çâ
Current Issues on the Treatment of Chronic Constipation

´ëÇѼÒÈ­±âÇÐȸÁö 2014³â 64±Ç 3È£ p.148 ~ p.153

È«°æ¼·(Hong Kyoung-Sup) - ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Á¤±â¿í(Jung Kee-Wook) - ¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ï¾Æ»êº´¿ø ¼ÒÈ­±â³»°úÇб³½Ç
ÀÌÅÂÈñ(Lee Tae-Hee) - ¼øõÇâ´ëÇб³ ÀÇ°ú´ëÇÐ ¼ÒÈ­±â¿¬±¸¼Ò
À̺ÀÀº(Lee Bong-Eun) - ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¹Ú¼±¿µ(Park Sun-Young) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
½ÅÁ¤Àº(Shin Jeong-Eun) - ´Ü±¹´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
±è¼ºÀº(Kim Seong-Eun) - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¹Ú°æ½Ä(Park Kyung-Sik) - °è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
ÃÖ¼®Ã¤(Choi Suck-Chei) - ¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç

Abstract

Chronic constipation is a very common clinical problem with its prevalence of up to 14% in the general population. It is not a life-threatening disease, but since patient¡¯s satisfaction to the treatment is known to be as low as 50%, chronic constipation still remains a clinically challenging problem. Fortunately, many new treatments have been introduced or are to be introduced in the near future. This article will review the basic concepts and the results of recent studies on the new treatments for chronic constipation.

Å°¿öµå

Constipation, Prucalopride, Lubiprostone, Linaclotide
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå